Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Holbech, Henrik [VerfasserIn]   i
 Matthiessen, Peter [VerfasserIn]   i
 Hansen, Martin [VerfasserIn]   i
 Schüürmann, Gerrit [VerfasserIn]   i
 Knapen, Dries [VerfasserIn]   i
 Reuver, Marieke [VerfasserIn]   i
 Flamant, Frédéric [VerfasserIn]   i
 Sachs, Laurent [VerfasserIn]   i
 Kloas, Werner [VerfasserIn]   i
 Hilscherova, Klara [VerfasserIn]   i
 Leonard, Marc [VerfasserIn]   i
 Arning, Jürgen [VerfasserIn]   i
 Strauss, Volker [VerfasserIn]   i
 Iguchi, Taisen [VerfasserIn]   i
 Baumann, Lisa [VerfasserIn]   i
Titel:ERGO
Titelzusatz:breaking down the wall between human health and environmental testing of endocrine disrupters
Verf.angabe:Henrik Holbech, Peter Matthiessen, Martin Hansen, Gerrit Schüürmann, Dries Knapen, Marieke Reuver, Frédéric Flamant, Laurent Sachs, Werner Kloas, Klara Hilscherova, Marc Leonard, Jürgen Arning, Volker Strauss, Taisen Iguchi and Lisa Baumann
E-Jahr:2020
Jahr:22 April 2020
Umfang:18 S.
Teil:volume:21
 year:2020
 number:8
 elocationid:2954
 pages:1-18
 extent:18
Fussnoten:Gesehen am 12.04.2021
Titel Quelle:Enthalten in: International journal of molecular sciences
Ort Quelle:Basel : Molecular Diversity Preservation International, 2000
Jahr Quelle:2020
Band/Heft Quelle:21(2020), 8, Artikel-ID 2954, Seite 1-18
ISSN Quelle:1422-0067
 1661-6596
Abstract:ERGO (EndocRine Guideline Optimization) is the acronym of a European Union-funded research and innovation action, that aims to break down the wall between mammalian and non-mammalian vertebrate regulatory testing of endocrine disruptors (EDs), by identifying, developing and aligning thyroid-related biomarkers and endpoints (B/E) for the linkage of effects between vertebrate classes. To achieve this, an adverse outcome pathway (AOP) network covering various modes of thyroid hormone disruption (THD) in multiple vertebrate classes will be developed. The AOP development will be based on existing and new data from in vitro and in vivo experiments with fish, amphibians and mammals, using a battery of different THDs. This will provide the scientifically plausible and evidence-based foundation for the selection of B/E and assays in lower vertebrates, predictive of human health outcomes. These assays will be prioritized for validation at OECD (Organization for Economic Cooperation and Development) level. ERGO will re-think ED testing strategies from in silico methods to in vivo testing and develop, optimize and validate existing in vivo and early life-stage OECD guidelines, as well as new in vitro protocols for THD. This strategy will reduce requirements for animal testing by preventing duplication of testing in mammals and non-mammalian vertebrates and increase the screening capacity to enable more chemicals to be tested for ED properties.
DOI:doi:10.3390/ijms21082954
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.3390/ijms21082954
 Volltext: https://www.mdpi.com/1422-0067/21/8/2954
 DOI: https://doi.org/10.3390/ijms21082954
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:adverse outcome pathway
 AOP
 biomarkers
 cross-species extrapolation
 endocrine disruption
 IATA
 integrated approach to testing and assessment
 OECD
 test guideline
 thyroid hormone disruption
K10plus-PPN:1753653754
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68722296   QR-Code
zum Seitenanfang